157 related articles for article (PubMed ID: 1900343)
1. Impaired activation of skeletal muscle glycogen synthase in non-insulin-dependent diabetes mellitus is unrelated to the degree of obesity.
Johnson AB; Argyraki M; Thow JC; Jones IR; Broughton D; Miller M; Taylor R
Metabolism; 1991 Mar; 40(3):252-60. PubMed ID: 1900343
[TBL] [Abstract][Full Text] [Related]
2. Reduced glycogen synthase activity in skeletal muscle from obese patients with and without type 2 (non-insulin-dependent) diabetes mellitus.
Damsbo P; Vaag A; Hother-Nielsen O; Beck-Nielsen H
Diabetologia; 1991 Apr; 34(4):239-45. PubMed ID: 1906024
[TBL] [Abstract][Full Text] [Related]
3. Effects of intensive dietary treatment on insulin-stimulated skeletal muscle glycogen synthase activation and insulin secretion in newly presenting type 2 diabetic patients.
Johnson AB; Argyraki M; Thow JC; Broughton D; Jones IR; Taylor R
Diabet Med; 1990 Jun; 7(5):420-8. PubMed ID: 2142039
[TBL] [Abstract][Full Text] [Related]
4. The impact of metformin therapy on hepatic glucose production and skeletal muscle glycogen synthase activity in overweight type II diabetic patients.
Johnson AB; Webster JM; Sum CF; Heseltine L; Argyraki M; Cooper BG; Taylor R
Metabolism; 1993 Sep; 42(9):1217-22. PubMed ID: 8412779
[TBL] [Abstract][Full Text] [Related]
5. The effect of acute (60 minute) insulin stimulation upon human skeletal muscle glycogen synthase and protein phosphatase-1 in non-insulin-dependent diabetic patients and control subjects.
Barriocanal LA; Borthwick AC; Stewart M; Wells A; Hurel SJ; Yeaman SJ; Taylor R
Diabet Med; 1995 Dec; 12(12):1110-5. PubMed ID: 8750222
[TBL] [Abstract][Full Text] [Related]
6. The effect of sulphonylurea therapy on skeletal muscle glycogen synthase activity and insulin secretion in newly presenting type 2 (non-insulin-dependent) diabetic patients.
Johnson AB; Argyraki M; Thow JC; Jones IR; Broughton D; Miller M; Taylor R
Diabet Med; 1991 Apr; 8(3):243-53. PubMed ID: 1828740
[TBL] [Abstract][Full Text] [Related]
7. In vivo insulin action and muscle glycogen synthase activity in type 2 (non-insulin-dependent) diabetes mellitus: effects of diet treatment.
Bak JF; Møller N; Schmitz O; Saaek A; Pedersen O
Diabetologia; 1992 Aug; 35(8):777-84. PubMed ID: 1511806
[TBL] [Abstract][Full Text] [Related]
8. Insulin-induced hexokinase II expression is reduced in obesity and NIDDM.
Pendergrass M; Koval J; Vogt C; Yki-Jarvinen H; Iozzo P; Pipek R; Ardehali H; Printz R; Granner D; DeFronzo RA; Mandarino LJ
Diabetes; 1998 Mar; 47(3):387-94. PubMed ID: 9519744
[TBL] [Abstract][Full Text] [Related]
9. Intracellular glucose metabolism after long term metabolic control with glyburide: improved glucose oxidation with unchanged glycogen synthase activity.
Suh KI; Murata C; Song YM; Joyce M; Gumbiner B; Ditzler TM; Henry RR
J Clin Endocrinol Metab; 1993 Aug; 77(2):464-70. PubMed ID: 8345053
[TBL] [Abstract][Full Text] [Related]
10. Effect of increased free fatty acid supply on glucose metabolism and skeletal muscle glycogen synthase activity in normal man.
Johnson AB; Argyraki M; Thow JC; Cooper BG; Fulcher G; Taylor R
Clin Sci (Lond); 1992 Feb; 82(2):219-26. PubMed ID: 1311661
[TBL] [Abstract][Full Text] [Related]
11. Decreased activation of skeletal muscle glycogen synthase by mixed-meal ingestion in NIDDM.
Wright KS; Beck-Nielsen H; Kolterman OG; Mandarino LJ
Diabetes; 1988 Apr; 37(4):436-40. PubMed ID: 2837418
[TBL] [Abstract][Full Text] [Related]
12. Irreversibility of the defect in glycogen synthase activity in skeletal muscle from obese patients with NIDDM treated with diet and metformin.
Damsbo P; Hermann LS; Vaag A; Hother-Nielsen O; Beck-Nielsen H
Diabetes Care; 1998 Sep; 21(9):1489-94. PubMed ID: 9727896
[TBL] [Abstract][Full Text] [Related]
13. Enhanced peripheral and splanchnic insulin sensitivity in NIDDM men after single bout of exercise.
Devlin JT; Hirshman M; Horton ED; Horton ES
Diabetes; 1987 Apr; 36(4):434-9. PubMed ID: 3102297
[TBL] [Abstract][Full Text] [Related]
14. Impaired activation of glycogen synthase in people at increased risk for developing NIDDM.
Schalin-Jäntti C; Härkonen M; Groop LC
Diabetes; 1992 May; 41(5):598-604. PubMed ID: 1568529
[TBL] [Abstract][Full Text] [Related]
15. Intracellular defects in glucose metabolism in obese patients with NIDDM.
Kelley DE; Mokan M; Mandarino LJ
Diabetes; 1992 Jun; 41(6):698-706. PubMed ID: 1587397
[TBL] [Abstract][Full Text] [Related]
16. Progressive defect of insulin action on glycogen synthase in obesity and diabetes.
Golay A; Munger R; Assimacopoulos-Jeannet F; Bobbioni-Harsch E; Habicht F; Felber JP
Metabolism; 2002 May; 51(5):549-53. PubMed ID: 11979384
[TBL] [Abstract][Full Text] [Related]
17. Lipolysis and gluconeogenesis from glycerol are increased in patients with noninsulin-dependent diabetes mellitus.
Puhakainen I; Koivisto VA; Yki-Järvinen H
J Clin Endocrinol Metab; 1992 Sep; 75(3):789-94. PubMed ID: 1517368
[TBL] [Abstract][Full Text] [Related]
18. Increased epinephrine and skeletal muscle responses to hypoglycemia in non-insulin-dependent diabetes mellitus.
Shamoon H; Friedman S; Canton C; Zacharowicz L; Hu M; Rossetti L
J Clin Invest; 1994 Jun; 93(6):2562-71. PubMed ID: 8200993
[TBL] [Abstract][Full Text] [Related]
19. Hyperglycaemia compensates for the defects in insulin-mediated glucose metabolism and in the activation of glycogen synthase in the skeletal muscle of patients with type 2 (non-insulin-dependent) diabetes mellitus.
Vaag A; Damsbo P; Hother-Nielsen O; Beck-Nielsen H
Diabetologia; 1992 Jan; 35(1):80-8. PubMed ID: 1541385
[TBL] [Abstract][Full Text] [Related]
20. Interaction of carbohydrate and fat fuels in human skeletal muscle: impact of obesity and NIDDM.
Mandarino LJ; Consoli A; Jain A; Kelley DE
Am J Physiol; 1996 Mar; 270(3 Pt 1):E463-70. PubMed ID: 8638694
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
